Quest Diagnostics: What The Heck Is Happening?

Quest Diagnostics Inc DGX is up nearly 10 percent on Friday after unconfirmed market chatter suggested the company has hired Goldman Sachs to explore a sale. Shares were halted on volatility at 10:34 am, and since resuming, shares hit the $86 mark before trading down near $81.

Bloomberg reporter Tara Lachapelle tweeted "is this $dgx and $lh stuff just an avon sequel...," adding: "avon part 2?" in a separate post.

Lachapelle has since deleted the tweet.

Related Link: Valeant CEO: Healthcare Sector A 'Bit Of A Bubble'

According to RBC Analyst Frank G. Morgan, "DGX's spike is probably just a rumor, things like this happen all the time." In an interview with Benzinga, Morgan highlighted the litany of unsubstantiated rumors that take place in the healthcare space.

More recently, Quest Diagnostics declined to comment on the share price move.

As of this writing, Quest is up 9.2 percent on the day.

date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorBiotechNewsShort IdeasRumorsExclusivesAnalyst RatingsTrading IdeasInterviewGeneralFrank G. MorganQuestquest diagnosticsRBC
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...